250 related articles for article (PubMed ID: 29530410)
1. High-mobility group box 1 protein (HMGB1) operates as an alarmin outside as well as inside cells.
Andersson U; Yang H; Harris H
Semin Immunol; 2018 Aug; 38():40-48. PubMed ID: 29530410
[TBL] [Abstract][Full Text] [Related]
2. The Janus face of HMGB1 in heart disease: a necessary update.
Raucci A; Di Maggio S; Scavello F; D'Ambrosio A; Bianchi ME; Capogrossi MC
Cell Mol Life Sci; 2019 Jan; 76(2):211-229. PubMed ID: 30306212
[TBL] [Abstract][Full Text] [Related]
3. Stretch Causes cffDNA and HMGB1-Mediated Inflammation and Cellular Stress in Human Fetal Membranes.
Padron JG; Saito Reis CA; Ng PK; Norman Ing ND; Baker H; Davis K; Kurashima C; Kendal-Wright CE
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791199
[TBL] [Abstract][Full Text] [Related]
4. Extracellular Vesicles and Damage-Associated Molecular Patterns: A Pandora's Box in Health and Disease.
Picca A; Guerra F; Calvani R; Coelho-Júnior HJ; Landi F; Bernabei R; Romano R; Bucci C; Marzetti E
Front Immunol; 2020; 11():601740. PubMed ID: 33304353
[TBL] [Abstract][Full Text] [Related]
5. Alarmins and Antitumor Immunity.
Nie Y; Yang D; Oppenheim JJ
Clin Ther; 2016 May; 38(5):1042-53. PubMed ID: 27101817
[TBL] [Abstract][Full Text] [Related]
6. Macrophage-derived HMGB1 is dispensable for tissue fibrogenesis.
Personnaz J; Piccolo E; Branchereau M; Filliol A; Paccoud R; Moreau E; Calise D; Riant E; Gourdy P; Heymes C; Schwabe RF; Dray C; Valet P; Pradère JP
FASEB Bioadv; 2019 Apr; 1(4):227-245. PubMed ID: 32123829
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of alarmins-S100A9, IL-33, HMGB1 and HIF-1α in supraspinatus tendinopathy before and after treatment.
Mosca MJ; Carr AJ; Snelling SJB; Wheway K; Watkins B; Dakin SG
BMJ Open Sport Exerc Med; 2017; 3(1):e000225. PubMed ID: 28761710
[TBL] [Abstract][Full Text] [Related]
8. The Yin and Yang of Alarmins in Regulation of Acute Kidney Injury.
Sabapathy V; Venkatadri R; Dogan M; Sharma R
Front Med (Lausanne); 2020; 7():441. PubMed ID: 32974364
[TBL] [Abstract][Full Text] [Related]
9. Alarmins in cutaneous malignant melanoma: An updated overview of emerging evidence on their pathogenetic, diagnostic, prognostic, and therapeutic role.
Papa V; Li Pomi F; Borgia F; Vaccaro M; Pioggia G; Gangemi S
J Dermatol; 2024 May; ():. PubMed ID: 38775220
[TBL] [Abstract][Full Text] [Related]
10. Targeting Inflammation Driven by HMGB1.
Yang H; Wang H; Andersson U
Front Immunol; 2020; 11():484. PubMed ID: 32265930
[TBL] [Abstract][Full Text] [Related]
11. Location is the key to function: HMGB1 in sepsis and trauma-induced inflammation.
Deng M; Scott MJ; Fan J; Billiar TR
J Leukoc Biol; 2019 Jul; 106(1):161-169. PubMed ID: 30946496
[TBL] [Abstract][Full Text] [Related]
12. HMGB1 and repair: focus on the heart.
Pellegrini L; Foglio E; Pontemezzo E; Germani A; Russo MA; Limana F
Pharmacol Ther; 2019 Apr; 196():160-182. PubMed ID: 30529040
[TBL] [Abstract][Full Text] [Related]
13. High Mobility Group Box-1 (HMGB1): A Potential Target in Therapeutics.
Vijayakumar EC; Bhatt LK; Prabhavalkar KS
Curr Drug Targets; 2019; 20(14):1474-1485. PubMed ID: 31215389
[TBL] [Abstract][Full Text] [Related]
14. Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signalling.
Paudel YN; Angelopoulou E; Piperi C; Balasubramaniam VRMT; Othman I; Shaikh MF
Eur J Pharmacol; 2019 Sep; 858():172487. PubMed ID: 31229535
[TBL] [Abstract][Full Text] [Related]
15. Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?
Andersson U; Ottestad W; Tracey KJ
Mol Med; 2020 May; 26(1):42. PubMed ID: 32380958
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation.
Yang H; Liu H; Zeng Q; Imperato GH; Addorisio ME; Li J; He M; Cheng KF; Al-Abed Y; Harris HE; Chavan SS; Andersson U; Tracey KJ
Mol Med; 2019 Apr; 25(1):13. PubMed ID: 30975096
[TBL] [Abstract][Full Text] [Related]
17. Immunological Significance of HMGB1 Post-Translational Modification and Redox Biology.
Kwak MS; Kim HS; Lee B; Kim YH; Son M; Shin JS
Front Immunol; 2020; 11():1189. PubMed ID: 32587593
[TBL] [Abstract][Full Text] [Related]
18. Interactions of high mobility group box protein 1 (HMGB1) with nucleic acids: Implications in DNA repair and immune responses.
Mandke P; Vasquez KM
DNA Repair (Amst); 2019 Nov; 83():102701. PubMed ID: 31563843
[TBL] [Abstract][Full Text] [Related]
19. HMGB1: A Common Biomarker and Potential Target for TBI, Neuroinflammation, Epilepsy, and Cognitive Dysfunction.
Paudel YN; Shaikh MF; Chakraborti A; Kumari Y; Aledo-Serrano Á; Aleksovska K; Alvim MKM; Othman I
Front Neurosci; 2018; 12():628. PubMed ID: 30271319
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]